Literature DB >> 17533511

Role of alpha adrenoceptors in the nucleus accumbens in the control of accumbal noradrenaline efflux: a microdialysis study with freely moving rats.

Y Aono1, T Saigusa, S Watanabe, T Iwakami, N Mizoguchi, H Ikeda, K Ishige, K Tomiyama, Y Oi, K Ueda, W-D Rausch, J L Waddington, Y Ito, N Koshikawa, A R Cools.   

Abstract

Microdialysis technique was used to study the effects of the locally applied alpha adrenoceptor agonist phenylephrine and antagonist phentolamine on the basal noradrenaline efflux as well as on the noradrenaline uptake inhibitor desipramine-elicited noradrenaline efflux in the nucleus accumbens (NAc) of freely moving rats. Tetrodotoxin reduced basal noradrenaline efflux by 72%, whereas desipramine increased it by 204%. Phenylephrine reduced the basal noradrenaline efflux by 32% and phentolamine blocked this effect. Phentolamine elevated the basal noradrenaline efflux by 150% and phenylephrine counteracted this effect. The desipramine-elicited noradrenaline efflux was not affected by phenylephrine, but enhanced by phentolamine. Desipramine counteracted the effects of phenylephrine and potentiated those of phentolamine. These results indicate that the accumbal noradrenaline efflux is under inhibitory control of alpha adrenoceptors that are suggested to be presynaptically located on adrenergic nerve terminals in the NAc. Furthermore, this study suggests that the conformational state of alpha adrenoceptors varies across the available amount of noradrenaline. The clinical impact of these data is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17533511     DOI: 10.1007/s00702-007-0745-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  42 in total

1.  Estimation of in-vivo neurotransmitter release by brain microdialysis: the issue of validity.

Authors:  G. Di Chiara; G. Tanda; E. Carboni
Journal:  Behav Pharmacol       Date:  1996-11       Impact factor: 2.293

2.  Adrenergic receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour.

Authors:  Hiroko Ikeda; Shoko Moribe; Michiko Sato; Ayako Kotani; Noriaki Koshikawa; Alexander R Cools
Journal:  Eur J Pharmacol       Date:  2006-10-17       Impact factor: 4.432

Review 3.  Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity.

Authors:  R D Oades; G M Halliday
Journal:  Brain Res       Date:  1987-05       Impact factor: 3.252

4.  Anatomy of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]-heat.

Authors:  L S Jones; L L Gauger; J N Davis
Journal:  J Comp Neurol       Date:  1985-01-08       Impact factor: 3.215

5.  The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.

Authors:  K Fusa; I Takahashi; S Watanabe; Y Aono; H Ikeda; T Saigusa; H Nagase; T Suzuki; N Koshikawa; A R Cools
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

6.  Determination of brain interstitial concentrations by microdialysis.

Authors:  H Benveniste; A J Hansen; N S Ottosen
Journal:  J Neurochem       Date:  1989-06       Impact factor: 5.372

7.  Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat.

Authors:  J M Delfs; Y Zhu; J P Druhan; G S Aston-Jones
Journal:  Brain Res       Date:  1998-09-28       Impact factor: 3.252

8.  Characterization of the synaptosomal high-affinity uptake of noradrenaline in the nucleus accumbens of rats.

Authors:  L Hetey; B Zimmermann
Journal:  Biomed Biochim Acta       Date:  1986

9.  High and low responders to novelty and mesolimbic noradrenaline: effects of noradrenergic agents on radial-maze performance.

Authors:  T Tuinstra; P Cobelens; L Lubbers; M Verheij; A R Cools
Journal:  Behav Neurosci       Date:  2002-12       Impact factor: 1.912

10.  Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers.

Authors:  M Y Li; Q S Yan; L L Coffey; M E Reith
Journal:  J Neurochem       Date:  1996-02       Impact factor: 5.372

View more
  7 in total

Review 1.  The role of the central noradrenergic system in behavioral inhibition.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res Rev       Date:  2011-03-05

Review 2.  Working mechanism underlying the reduction of the behavioral and accumbal dopamine response to cocaine by α-1-adrenoceptor antagonists.

Authors:  Michel M M Verheij; Tadashi Saigusa; Noriaki Koshikawa; Alexander R Cools
Journal:  Neuropsychopharmacology       Date:  2013-02       Impact factor: 7.853

3.  Cannabinoid modulation of limbic forebrain noradrenergic circuitry.

Authors:  Ana F Carvalho; Kenneth Mackie; Elisabeth J Van Bockstaele
Journal:  Eur J Neurosci       Date:  2010-01-13       Impact factor: 3.386

4.  Marked behavioral activation from inhibitory stimulation of locus coeruleus alpha1-adrenoceptors by a full agonist.

Authors:  Eric A Stone; Yan Lin; Yasmeen Sarfraz; David Quartermain
Journal:  Brain Res       Date:  2009-07-24       Impact factor: 3.252

5.  Accumbal noradrenaline that contributes to the alpha-adrenoceptor-mediated release of dopamine from reserpine-sensitive storage vesicles in the nucleus accumbens is derived from alpha-methyl-para-tyrosine-sensitive pools.

Authors:  M M M Verheij; A R Cools
Journal:  J Neural Transm (Vienna)       Date:  2009-02-17       Impact factor: 3.575

6.  The involvement of noradrenaline in rapid eye movement sleep mentation.

Authors:  Claude Gottesmann
Journal:  Front Neurol       Date:  2011-12-12       Impact factor: 4.003

7.  Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors.

Authors:  Francisca Meyer; Judith Latour; Alexander R Cools; Michel M M Verheij
Journal:  Front Cell Neurosci       Date:  2014-08-21       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.